🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07186959
Enrolling by invitation Not applicable

EGPSS for Weight Management in an in Vivo Human Model

NCT07186959 · tracked via the Priya Life Science China tracker
Sponsor
Liu Yan
Phase
Not applicable
Started
2024-07-01
Last updated
2025-09-22

Condition(s) studied

Obesity, Mild

Investigational drug(s) / intervention(s)

endoscopic gastric purse-string suturing

endoscopic gastric purse-string suturing: A dual-tail endoloop will be introduced into the stomach with endoscopic forceps, and will be secured to the gastric wall using endoscopic clips. An endoscope hook was used to tighten both tails of the endoloop until all the clips converged.

Study summary

ndoscopic bariatric and metabolic therapies (EBMTs) have introduced more convenient, minimally invasive, and safe approaches to weight management. Mucosal ablation of the gastric fundus has been reported to limit fundic expansion and promote satiety; however, ablation can cause perforation, infection, bleeding, and other complications. To restrain fundic expansion while minimizing surgical trauma and preserving reversibility, an endoscopic gastric purse-string suturing (EGPSS) technique was developed to reduce gastric volume. This procedure may be suitable for short-term weight management. Safety and feasibility were demonstrated in a porcine model. The present study will evaluate the feasibility of EGPSS in participants with obesity and assess histological and physiological outcomes.

Eligibility

Sex
ALL
Min age
18 Years
Max age
70 Years
Healthy volunteers
No
Inclusion criteria: * Patients with a body mass index (BMI) of 24-35 kg / m²; * Patients accepted Lifestyle modifications, pharmacological interventions for weight loss which were unsuccessful or experienced a weight rebound; * Patients willing to loss weight; * Obese patients with metabolic disorders. Exclusion criteria: * Women who are planning to conceive, pregnant, or breastfeeding; * Patients who are suffering from severe organ failure requiring hospitalization; * Patients who have undergone gastrectomy; * Patients allergic to anesthetics.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
The fifth Medical Center of Chinese PLA General Hospital Beijing Beijing Municipality

More Liu Yan trials in China

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07186959 on ClinicalTrials.gov ↗ ← All trials in China